Hydrophilic Drugs
Hydrophilic Drugs - Related Videos
03:07
Hydrophilic Interaction Liquid Chromatography: A Technique to Separate Hydrophilic Polar Analytes Using Hydrophilic Beads
0 Views •
2025
This video demonstrates the principle of separation of hydrophilic polar compounds using hydrophilic interaction liquid chromatography. This technique helps in the purification of various polar analytes, including N-glycans.
09:01
A Protocol for the Production of Gliadin-cyanoacrylate Nanoparticles for Hydrophilic Coating
0 Views •
2016
This article presents a protocol for the production of protein-based nanoparticles that changes the hydrophobic surface to hydrophilic. The produced nanoparticle is an assembly of gliadin-cyanoacrylate diblock copolymers. Spray coating with the produced nanoparticle changes the surface of target material to a hydrophilic surface.
09:09
Synthesis of Poly(N-isopropylacrylamide) Janus Microhydrogels for Anisotropic Thermo-responsiveness and Organophilic/Hydrophilic Loading Capability
0 Views •
Cited by 3 •
2016
We present a protocol to synthesize Janus microhydrogels composed entirely of the same base material, poly(N-isopropylacrylamide) (PNIPAAm), with a clearly compartmentalized structure base on the phase separation of a supersaturated NIPAAm monomer solution. The synthesized Janus microhydrogels show unique properties such as anisotropic thermo-responsiveness and organophilic/hydrophilic loading capability.
10:12
Flash NanoPrecipitation for the Encapsulation of Hydrophobic and Hydrophilic Compounds in Polymeric Nanoparticles
0 Views •
Cited by 72 •
2019
Flash NanoPrecipitation (FNP) is a scalable approach to produce polymeric core-shell nanoparticles. Lab-scale formulations for the encapsulation of hydrophobic or hydrophilic therapeutics are described.
00:11
Preparation and Characterization of Nanoliposomes for the Entrapment of Bioactive Hydrophilic Globular Proteins
0 Views •
Cited by 15 •
2019
This study describes classical hydration using the thin lipid film method for nanoliposome preparation followed by nanoparticle characterization. A 47 kDa-hydrophilic and globular protein, tarin, is successfully encapsulated as a strategy to improve stability, avoid fast clearance, and promote controlled release. The method can be adapted to hydrophobic molecules encapsulation.
FAQs
Their movement across membranes depends on pathways that provide access through aqueous environments. These may include aqueous channels, spaces between cells, or membrane transporters that facilitate passage. The relative contribution of each pathway influences which barriers a drug can cross, how rapidly it reaches tissues, and whether transporter activity becomes important for its pharmacological effects.
Transporters can provide a route across membranes that the drug would otherwise cross inefficiently. Their activity therefore influences absorption, tissue distribution, and access to pharmacological targets. Changes in transporter-mediated movement can also alter drug concentrations and create clinically relevant interactions, making transporter assessment important when predicting exposure and optimizing treatment.
Because gastrointestinal barriers can restrict absorption, the selected administration route may substantially affect systemic exposure. Oral delivery depends on the drug reaching and crossing relevant aqueous or transporter-mediated pathways, whereas routes that bypass gastrointestinal barriers can change bioavailability and onset. Pharmacologists consider these differences when selecting formulations and designing treatment strategies.
Tissue penetration reflects the drug’s ability to move through body fluids and cross the biological barriers surrounding the tissue. Limited membrane partitioning can restrict access, while aqueous channels, paracellular pathways, or transporters may support movement. These factors help explain differences in drug concentrations among tissues and can influence the timing and strength of pharmacological effects.
Assessment focuses on how the compound dissolves, moves through aqueous environments, crosses relevant barriers, and reaches its target. Researchers also consider administration route, formulation, transporter-mediated movement, expected concentrations, and renal elimination. Integrating these factors helps predict exposure, identify possible interactions, and select an approach that supports the intended therapeutic effect.
Renal elimination is an important determinant of how long a hydrophilic drug remains in the body. Its water-associated behavior supports movement through body fluids toward renal clearance, while the overall elimination process affects drug concentrations and duration of action. Considering this relationship helps pharmacologists interpret exposure and plan therapies around the desired effect.
This pharmacological understanding supports therapy development across infections, cancer, cardiovascular disease, and other conditions. In each setting, researchers can relate membrane passage, transporter activity, formulation, tissue penetration, and elimination to drug exposure and target access. That information helps guide treatment optimization rather than relying only on the drug’s intended molecular target.